Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Actinic Keratosis Market from 2024 to 2025?
The market scale of actinic keratosis has seen a stable increase in previous years. It’s projected to rise from $7.95 billion in 2024 to $8.44 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this growth during the history period include heightened exposure to UV rays, an aging population, heightened awareness about skin cancer, a growing incidence rate of actinic keratosis, expanded healthcare infrastructure, increased disposable incomes, supportive government schemes, and a heightened emphasis on preventative skincare.
What Is the Projected Market Size of the Actinic Keratosis Market?
Growth is predicted to explode in the actinic keratosis market over the coming years, reaching a valuation of $10.58 billion in 2029 with a compound annual growth rate (CAGR) of 7.4%. This predicted expansion during the forecasted period can be linked to various factors including the introduction of innovative therapies, AI-driven diagnostic tool advancements, the increased uptake of combination treatments, and a growing demand for non-intrusive procedures. A rise in tele dermatology use, the increasing use of photodynamic therapy, heightened awareness around cosmetic results, development of targeted biologic treatments, increased investment in healthcare within emerging markets, and a stronger emphasis on early detection and prevention are also contributing factors in this growth. Looking at the trends during the forecast period, the prominence of AI-powered diagnostic tools, machine-learning-enabled lesion analysis, advanced systems for photodynamic therapy, wearable UV monitors, nanotechnology-oriented drug delivery, 3D imaging for personalized treatments, home-based portable phototherapy devices, early detection biosensors, automated software for lesion classification, and therapeutic systems based on hydrogel are expected to take the lead.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21077&type=smp
Who are the Major Competitors in the Actinic Keratosis Market Outlook?
Major companies operating in the actinic keratosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb, Novartis AG, GSK plc, Amgen Inc., Bausch Health Companies Inc., Perrigo Company plc, Galderma SA, Incyte Corporation, Leo Pharma Inc., Almirall S.A., Athenex Inc., G&E Herbal Biotechnology Co. Ltd., Aclaris Therapeutics Inc., Biofrontera Inc., Hill Dermaceuticals Inc.
What Is Fueling Growth in the Actinic Keratosis Market?
The upward trend in extreme sunburn cases is predicted to drive the expansion of the actinic keratosis market. Extreme sunburns involve severe skin damage brought on by excessive ultraviolet (UV) radiation exposure, leading to symptoms such as redness, pain, swelling and sometimes, blisters. Factors contributing to sunburns include sustained UV radiation exposure, failure to take adequate sun protection precautions, escalating outdoor activities during periods of peak UV exposure and rising temperatures induced by climate change. Sunburn-induced actinic keratosis occurs through UV radiation damaging skin cell DNA, causing mutations that interfere with regular cellular function and manifesting in precancerous lesions, especially when the skin is repeatedly or enduringly exposed to the sun. For example, the Melanoma Focus, a charity organization in the UK, reported in May 2024 that in 2022-23, sunburn resulted in 201 hospital admissions, with 89 of the patients being children and 25, babies under the age of one. The charity further revealed that 66% of UK adults between the ages of 16-65 recalled instances of sunburn as children, and 65% of them had suffered at least one episode of extreme sunburn with blisters. This proportion increased to 77% among those with light, pale or white complexion. Hence, the escalating instance of severe sunburns is fuelling the actinic keratosis market’s growth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21077&type=smp
Which Actinic Keratosis Market Segments Are Growing the Fastest?
The actinic keratosis market covered in this report is segmented –
1) By Treatment Type: Topical Treatment, Surgical Procedure, Photodynamic Therapy, Other Treatment Types
2) By Distribution Channels: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
3) By End-User: Hospitals, Dermatology Clinics, Spas And Rejuvenation Centers, Homecare Settings, Other End-Users
Subsegments:
1) By Topical Treatment: 5-Fluorouracil (5-FU), Imiquimod, Diclofenac, Ingenol Mebutate, Retinoids
2) By Surgical Procedure: Cryotherapy, Curettage And Electrodessication, Excision
3) By Photodynamic Therapy: Aminolevulinic Acid (ALA) Plus Light Therapy, Methyl Aminolevulinate (MAL) Plus Light Therapy
4) By Other Treatment Types: Laser Therapy, Chemical Peels, Combination Therapies
Which Industry Trends Are Shaping the Future of the Actinic Keratosis Market?
The focus of major players in the actinic keratosis market is on the creation of topical ointments that can efficiently target and eliminate precancerous lesions, diminish recurrences, and boost patient adherence through reduced treatment periods and better safety profiles. These topical creams or gels employ an active ingredient such as tirbanibulin to directly treat the affected skin, targeting abnormal keratinocytes that cause precancerous lesions. An example of this is Almirall SA, a biopharmaceutical firm from Spain, which in June 2024, received approval from the US Food and Drug Administration (FDA) for its supplemental new drug application (sNDA) to broaden the utilization of its drug, Klisyri, up to 100 cm2. Klisyri (tirbanibulin) 1% ointment acts as a microtubule inhibitor, preventing the growth of abnormal keratinocytes and effectively reducing the number and size of precancerous lesions for the treatment of actinic keratosis (AK) on the face or scalp.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/actinic-keratosis-global-market-report
Which Countries Are Leading the Actinic Keratosis Market?
North America was the largest region in the actinic keratosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the actinic keratosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21077
This Report Delivers Insight On:
1. How big is the actinic keratosis market, and how is it changing globally?
2. Who are the major companies in the actinic keratosis market, and how are they performing?
3. What are the key opportunities and risks in the actinic keratosis market right now?
4. Which products or customer segments are growing the most in the actinic keratosis market?
5. What factors are helping or slowing down the growth of the actinic keratosis market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model